Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    • Immunodeficiency NOT (AIDS OR Stem Cell)
Show Display Options
RSS Create an RSS feed from your search for:
• Immunodeficiency NOT (AIDS OR Stem Cell)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push
Condition: Primary Immunodeficiency
Interventions: Device: Chrono Super PID then Generic Syringe-Gammanorm;   Device: Generic Syringe then Chrono Super PID-Gammanorm
2 Recruiting Study of Efficacy of CDZ173 in Patients With APDS/PASLI
Condition: Activated PI3Kdelta Syndrome (APDS); p110delta-activating Mutation Causing Senescent T Cells, Lymphadenopathy and Immunodeficiency (PASLI)
Intervention: Drug: CDZ173
3 Completed
Has Results
Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans
Condition: Immunologic Deficiency Syndromes
Intervention: Dietary Supplement: Beta-glucan (Glucan #300®)

Study has passed its completion date and status has not been verified in more than two years.